Determination of the Minimal Clinically Important Difference After Treatment With Pantoprazole in Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-340)

NCT00246909 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
600
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda